Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey

Author: Monk Bradley J.   Lammers Philip E.   Cartwright Thomas   Jacobs Ira  

Publisher: MDPI

E-ISSN: 1424-8247|10|1|19-19

ISSN: 1424-8247

Source: Pharmaceuticals, Vol.10, Iss.1, 2017-01, pp. : 19-19

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content